Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 4137
  • 4138
  • 4139
  • …
  • ›
  • »

2026-05-06

How Aehr Test Systems Stock Rose 144% Last Month

2026-05-06

Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for aprevo lumbar

2026-05-06

Advance Metals spinning the bit at Gavilanes silver project in Mexico

2026-05-06

LBL-047 Prioritized for Clinical Development in Sjögren′s Disease, Systemic Lupus Erythematosus, and Dermatomyositis

2026-05-06

Emerson forecasts $6.45 to $6.55 EPS as it updates 2026 sales growth to 4.5% amid Middle East disruption

2026-05-06

AML3D Deploys First Portable ARCEMY System at US Navy AM CoE

2026-05-06

Alphatec forecasts $882M 2026 revenue while keeping adjusted EBITDA at $134M

2026-05-06

Compared to Estimates, Qorvo (QRVO) Q4 Earnings: A Look at Key Metrics

2026-05-06

Mueller Water Products (MWA) Reports Q2 Earnings: What Key Metrics Have to Say

2026-05-06

Here′s What Key Metrics Tell Us About Pan American Silver (PAAS) Q1 Earnings

2026-05-06

Bright Horizons reaffirms 2026 adjusted EPS of $4.90 to $5.10 while raising Back-Up Care growth outlook to 12% to 14%

2026-05-06

Adaptive Biotechnologies raises 2026 MRD revenue view to $260M-$270M while targeting positive adjusted EBITDA and free cash flow by end of 2026

  • «
  • ‹
  • …
  • 4137
  • 4138
  • 4139
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies